Coronavirus Disease (COVID-19): Pathophysiology, Epidemiology

COVID-19 and Cardiology

Coronavirus, SARS-CoV-2 Portal Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Frontiers Editorial: Coronavirus Disease (COVID-19): Pathophysiology, Epidemiology, Clinical Management and Public Health Response, Volume II

EDITORIAL GRAPHENE and DERIVATES CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERTIES IN m RNA vaccine MANIFACTURING STRATEGY - STATE OF EVIDENCE

The Pathogenesis and Long-Term Consequences of COVID-19 Cardiac Injury - ScienceDirect

Coronavirus COVID-19 Viral Structure & Pathogenesis

EDITORIAL GRAPHENE and DERIVATES CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERTIES IN m RNA vaccine MANIFACTURING STRATEGY - STATE OF EVIDENCE

Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management

Frontiers Grand Challenges in Infectious Diseases: Are We Prepared for Worst-Case Scenarios?

EDITORIAL GRAPHENE and DERIVATES CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERTIES IN m RNA vaccine MANIFACTURING STRATEGY - STATE OF EVIDENCE

Impact Factor 5.085 - Citescore 5.4 More On Impact, PDF, Interferon

A schematic diagram of COVID-19 pathophysiology. The SARS-CoV-2 binds

Post-acute COVID-19 syndrome